11. Patologi

Busch, C., & Algaba, F. (2002). The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Archiv : an international journal of pathology, 441(2), 105-8.

Cancer Incidence in Five Continents (2007). (IARC Scientific Publications No. 160). Lyon: IARC.

Chen, Z., Ding, W., Xu, K., Tan, J., Sun, C., Gou, Y., ... Ding, Q. (2012). The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer. PLoS one, 7(10), e47199.

Choi, W., Ochoa, A., McConkey, D. J., Aine, M., Höglund, M., Kim, W. Y., ... Lerner, S. P. (2017). Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. European urology, 72(3), 354-365.

Dinney, C. P., McConkey, D. J., Millikan, R. E., Wu, X., Bar-Eli, M., Adam, L., ... Czerniak, B. (2004). Focus on bladder cancer. Cancer cell, 6(2), 111-6.

El-Bolkainy, M. N., Chu, E. W., Ghoneim, M. A., & Ibrahim, A. S. (1982). Cytologic detection of bladder cancer in a rural Egyptian population infected with schistosomiasis. Acta cytologica, 26(3), 303-10.

Epstein, J. I., Amin, M. B., Reuter, V. R., & Mostofi, F. K. (1998). The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. The American journal of surgical pathology, 22(12), 1435-48.

Eriksson, P., Aine, M., Veerla, S., Liedberg, F., Sjödahl, G., & Höglund, M. (2015). Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems. BMC medical genomics, 8, 25.

Gönul, ,. I., Akyürek, N., Dursun, A., & Küpeli, B. (2008). Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. Pathology, research and practice, 204(10), 707-17.

Kim, S. P., Frank, I., Cheville, J. C., Thompson, R. H., Weight, C. J., Thapa, P., & Boorjian, S. A. (2012). The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. The Journal of urology, 188(2), 405-9.

Kirkali, Z., Chan, T., Manoharan, M., Algaba, F., Busch, C., Cheng, L., ... Weider, J. (2005). Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology, 66(6 Suppl 1), 4-34.

Lee, Y. J., Moon, K. C., Jeong, C. W., Kwak, C., Kim, H. H., & Ku, J. H. (2014). Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma. PLoS one, 9(9), e107027.

Mostofi, F. K., Sobin, L. H., Torloni, H. (1973). Histological typing of urinary bladder tumours (International histological classification of tumours No. 10). Geneva: World Health Orgaization. Hentet fra http://apps.who.int/iris/bitstream/10665/41533/1/9241760109_eng.pdf

Oosterhuis, J. W., Schapers, R. F., Janssen-Heijnen, M. L., Pauwels, R. P., Newling, D. W., & ten Kate, F. (2002). Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. Journal of clinical pathology, 55(12), 900-5.

Sharks, J. H., Chandra, A., McWilliam, L., Varma, M. (2013). Standards and datasets for reporting cancers: dataset for tumours of the urinary collecting system (renal pelvis, ureter, urinary bladder and urethra) (2 utg.) London: The Royal College of Pathologists. Hentet fra https://www.rcpath.org/asset/E2C11FF6-780A-471E-A21A4DC48788D35B/

Sylvester, R. J., van der Meijden, A. P., Oosterlinck, W., Witjes, J. A., Bouffioux, C., Denis, L., ... Kurth, K. (2006). Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. European urology, 49(3), 466-5; discussion 475-7.

van Rhijn, B. W., van der Kwast, T. H., Vis, A. N., Kirkels, W. J., Boevé, E. R., Jöbsis, A. C., & Zwarthoff, E. C. (2004). FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer research, 64(6), 1911-4.

Van Der Meijden, A., Sylvester, R., Collette, L., Bono, A., & Ten Kate, F. (2000). The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials. The Journal of urology, 164(5), 1533-7.

Veileder i biopsibesvarelse av maligne svulster (2016). (3 utg.) Oslo: Hentet fra http://legeforeningen.no/Global/Fagmedisinske%20foreninger/Den%20norske%20patologforening/Veileder%20i%20besvarelse%20av%20maligne%20svulster%202016%203%20%20utgave.pdf

Wasco, M. J., Daignault, S., Zhang, Y., Kunju, L. P., Kinnaman, M., Braun, T., ... Shah, R. B. (2007). Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology, 70(1), 69-74.